Synthetic gene circuits for the detection, elimination and prevention of disease. (June 2018)

• Record Type: Journal Article
• Authors: Sedlmayer, Ferdinand; Aubel, Dominique; Fussenegger, Martin
• Is Part Of: Nature biomedical engineering. Volume 2:Number 6(2018)
• Page Start: 399
• Page End: 415
• Publication Date: 2018-06
• Subjects: Biomedical engineering -- Periodicals; 610.2805
• DOI: 10.1038/s41551-018-0215-0
• Languages: English
• ISSNs: 2157-846X

Abstract

Abstract In living organisms, naturally evolved sensors that constantly monitor and process environmental cues trigger corrective actions that enable the organisms to cope with changing conditions. Such natural processes have inspired biologists to construct synthetic living sensors and signalling pathways, by repurposing naturally occurring proteins and by designing molecular building blocks de novo, for customized diagnostics and therapeutics. In particular, designer cells that employ user-defined synthetic gene circuits to survey disease biomarkers and to autonomously re-adjust unbalanced pathological states can coordinate the production of therapeutics, with controlled timing and dosage. Furthermore, tailored genetic networks operating in bacterial or human cells have led to cancer remission in experimental animal models, owing to the network's unprecedented specificity. Other applications of designer cells in infectious, metabolic and autoimmune diseases are also being explored. In this Review, we describe the biomedical applications of synthetic gene circuits in major disease areas, and discuss how the first genetically engineered devices developed on the basis of synthetic-biology principles made the leap from the laboratory to the clinic. This Review discusses the main diagnostic and therapeutic applications of synthetic gene circuits, and their translational prospects.